chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from an RN concerning a 64 year old female who on 15DEC2003 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine. On approximately 15DEC2003 the pt experienced redness, soreness and heat at the injection site and malaise. Unspecified medical attention was sought. There was no product quality complaint involved. The reporter indicated that two other pts had similar experiences following exposure to pneumococcal 23v polysaccharide vaccine. Additional information has been requested.
Headaches lasting longer than 2 days. Injection on 1/3/19, headache started 1/4/19, as of today 1/8/19, headache persists.
Pt had just been cleared for surgery on a broken toe and passed away unexpectedly 3 days before scheduled surgery.
This spontaneous report as received from a pharmacist refers to a 17-year-old patient of unknown gender with no pertinent medical history. On an unknown date, the patient was inadvertently administered PEDVAXHIB, intramuscular (dose, lot number and expiration date were not reported). No adverse effects reported. Additional information has been requested.
Sore arm, but then redness and hot to touch. Felt ill.  Stayed hot 8 days later. Reported this to my dr on March 24, 2021
My mom received shingles vac. on 7/15/09. In May she developed a very intense case of shingles & developed severe neuropathy in her left leg & abdomen. She was hospitalized for about 6 weeks had to move to assisted living, never fully recovered & died 10/26/10.
Fainting 14 hours after shot; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the right arm on 29Apr2021 at 08:30 (batch/lot number: EW0173) as 2nd dose, single for COVID-19 immunization. Medical history included known allergies to penicillin. The patient was not pregnant. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 1st dose on 08Apr2021 at 09:30 (lot number: EW0158) administered in the right arm for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was public health clinic/veterans administration facility. No other vaccine in four weeks and no other medications in two weeks. The patient experienced fainting 14 hours after shot on 29Apr2021 at 23:15. No treatment was received for the adverse event. No Covid prior to vaccination. The patient was Covid tested post vaccination which included Covid test type nasal swab with unknown result on an unspecified date. The outcome of the event was recovered on an unspecified date.  Information on the lot/batch number has been received. Further information has been requested.
Can you catch covid in between doses since I have been coughing even though I am a smoker?; This is a spontaneous report from a contactable consumer (patient). An unspecified age of female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution of injection, Lot Number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Medical history included smoker from an unspecified date and ongoing. The patient concomitant medications were not reported. On an unspecified date in Apr2021, the patient experienced can you catch covid in between doses since I have been coughing even though I am a smoker. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Office did not adhere to standard work. Drew up all doses from vial in the morning and discarded vial without doing a double check.. Proceeded to use a sticky note with bivalent NDC, lot and expiration for documentation in EMR. Several weeks into the process they realized that some days they had pulled and administered monovalent instead of the intended bivalent booster.
Patient's representative called today (11/15/17) and stated that the patient's left arm was red, swollen, and painful around the injection site. I encouraged her to take the patient to see a Doctor for further evaluation. I later spoke with patient and again encouraged him to seek medical attention. He stated that he may go see his PCP tomorrow if it doesn't improve.
pt recv vax 1JUN98 & 1JUN98 refused bottle, cried self to sleep;cried like was in pain for 15min, fell asleep for 30min, repeated cycle until 8JUN98;2JUN98-5JUN98 weak, limp, pale no rxn to stimulus, no spontaneous movement;diarrhea,vomitin
Systemic: Headache, Systemic: Nausea, Systemic: tinnitus, sweating, shortness of breath
Local symptoms: Pain-discomfort, redness. General symptoms: hypotension, vision and sweating decreased.  Narrative:
This is an initial spontaneous report by a contactable consumer. This female consumer reported for her 3 year old son received PREVNAR 13 on 24Nov2010 for the treatment of pneumonia. Relevant medical history was none. Relevant concomitant medications were none. On 26Nov2010, the patient experienced an unspecified reaction. Treatment included prednisone. Relevant tests included blood work performed on 30Nov2010. Results were unknown. Patient not yet recovered at time of report. Follow-up (09FEB2010): New information reported from a contactable physician included the site of the PREVNAR 13 injection (left deltoid), the lot number (914971) with expiration date (3/2012) and the date of the adverse event onset as 25Nov2010. The physician reported this 3-year-old male patient developed a red, swollen area 7" x 5" in size over left deltoid at site of PREVNAR injection; patient later developed hives over feet.  At the time of this report, it is unknown if the patient has recovered.
About three hours after receiving the vaccine, the person had some lower lip and chin numbness. Patient had flu shots in the past with no problems. Recommend she go to the E.R. She went to an emergency clinic and the physician said she had a mild anaphylactic reaction. At this point did have facial swelling. She was treated. Follow-up call to this person the next day found her to be fine. Follow up report received on 04/28/2005:  Allergic reaction related to Motrin allergy.
local redness at site (L) arm upper site red and swollen warm to the touch itchiness Increased pain after rec DTaP
fever the noc following vax but temp not measured; reported not feeding much; mom woke @ noon finding baby unresponsive, no resp, lips & feet blue;
I had fever around 101 the first two days, fatigue, headache and vertigo. I had a low grade fever of 99.1/2 for approx. 8 more days with headache and vertigo. As of today I still have mild vertigo/dizziness and dull headache--- no fever.
My throat's sore; Mucousy; If I'm getting sick I don't need to go get the shot; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (My throat's sore), PRODUCTIVE COUGH (Mucousy) and ILLNESS (If I'm getting sick I don't need to go get the shot) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient experienced OROPHARYNGEAL PAIN (My throat's sore), PRODUCTIVE COUGH (Mucousy) and ILLNESS (If I'm getting sick I don't need to go get the shot). At the time of the report, OROPHARYNGEAL PAIN (My throat's sore), PRODUCTIVE COUGH (Mucousy) and ILLNESS (If I'm getting sick I don't need to go get the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant informations were reported. No treatment informations were reported.
my heart is racing; Cannot function with every day things that normal people do; Will take 10 steps before losing control of her legs and can't walk anymore; I am so exhausted from this vaccine; I am getting nervous; I feel like shit; this is not normal I do not feel good; feel horrible; Joint pain; my hand shake; shaking everything; This is a spontaneous report from a Pfizer sponsored program received from a Consumer (the patient).    A 42-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 01Sep2021 (Batch/Lot Number: F-3184) as single dose for covid-19 immunisation  .  The patient medical history and concomitant medications were not reported.  The patient experienced my heart is racing  (medically significant) on 2021 with outcome of unknown , cannot function with every day things that normal people do (medically significant) on 2021 with outcome of unknown , will take 10 steps before losing control of her legs and can't walk anymore  (medically significant) on 2021 with outcome of unknown , I am so exhausted from this vaccine  (non-serious) on 2021 with outcome of unknown , I am getting nervous  (non-serious) on 2021 with outcome of unknown , I feel like shit; this is not normal i do not feel good; feel horrible  (non-serious) on 2021 with outcome of unknown , joint pain (non-serious) on 2021 with outcome of unknown , my hand shake; shaking everything  (non-serious) on 2021 with outcome of unknown.  Follow-Up (13Sep2021): Follow-up attempts are completed. No further information is expected.
Child was given a half dose out of the 12+ Pfizer bivalent.  It was split between his sister who is 12 years old and should have gotten a full dose.  This child should have gotten the 5-11 year old bivalent.  Not sure what the next steps are for either child.  See E-number.
Headache, swollen ankles, bilateral knee pain, extreme fatigue.  *The extreme fatigue persists. Prior to the vaccine patient walked on the treadmill for 1hour or more 5 to 7 days per week. The patient is now barely able to tolerate 30 minutes of exercise every other day. Exercise leaves the patient fatigued.
had COVID-19 a few weeks ago and it was mild.; had COVID-19 a few weeks ago and it was mild.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the patient.  An elderly female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "had COVID-19 a few weeks ago and it was mild.". Clinical course: Patient used Pfizer for her vaccine and that seems to had worked well. Patient had COVID-19 a few weeks ago and that was mild.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
migraine headache; sleep apnea; incontinence in going to bathroom.; Depression; Runny nose; cough; She didn't get 2nd dose due to all these side effects; chills; fatigue; body aches; fever; muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), SLEEP APNOEA SYNDROME (sleep apnea), URINARY INCONTINENCE (incontinence in going to bathroom.), DEPRESSION (Depression) and RHINORRHOEA (Runny nose) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN, LISINOPRIL and VITAMIN D2 for an unknown indication.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, the patient experienced MUSCLE SPASMS (muscle spasms), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches) and PYREXIA (fever). On an unknown date, the patient experienced MIGRAINE (migraine headache), SLEEP APNOEA SYNDROME (sleep apnea), URINARY INCONTINENCE (incontinence in going to bathroom.), DEPRESSION (Depression), RHINORRHOEA (Runny nose), COUGH (cough) and PRODUCT DOSE OMISSION ISSUE (She didn't get 2nd dose due to all these side effects). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and TRAMADOL at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine headache), SLEEP APNOEA SYNDROME (sleep apnea), URINARY INCONTINENCE (incontinence in going to bathroom.), DEPRESSION (Depression), RHINORRHOEA (Runny nose), MUSCLE SPASMS (muscle spasms), COUGH (cough), CHILLS (chills), FATIGUE (fatigue), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (She didn't get 2nd dose due to all these side effects) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment drugs included
The pt experienced constant screaming for 24 hours post vax, with vomiting with some feedings for 2-3 days. The pt also experienced a URI for 2 weeks.
Shortness of Breath; tightness on her throat; Neck pain; shoulder pain; This is a spontaneous report from a contactable consumer (patient) received via Pfizer sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: not reported,), via an unspecified route of administration on 01Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that after her first shot she experienced tightness on her throat, Shortness of Breath, Neck pain and shoulder pain. She had her first shot 01Mar2021 and scheduled to get her second dose on 29Mar2021. She took Benadryl after her first shot. The clinical outcome for the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot been obtained.
A report has been received from a Health Professional concerning a 39 year old, female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on 01-DEC-2014. The patient was administered expired FLUMIST on 01-DEC-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Treatment of COVID-19; Treatment of COVID-19; Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 31Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 28Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 11Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 26Sep2022, outcome "unknown", described as "Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: The patient received Paxlovid from 18Feb2023 to 22Feb2023 as treatment of COVID-19. The patient has no known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
11 Days after receiving the Moderna booster on 2/12/22 I woke up with red hives on both of my arms. Went to medical facility, got the usual questions about allergies or any new substances I may have used. Not a single change in my lifestyle except for this booster. Was prescribed Benadryl, but the hives spread all over my body the next morning. I then went on 50 mg of Prednisone a day, which calmed down the hives, but did not help. They then moved to my face, scalp, and honestly all over my entire body. On day 14 after the booster, I went into anaphylactic shock. Feet were swollen to the point where I could not walk, hives were all over my face and chest, heart was beating irregularly, chest was tight, lips were itching, and I was having trouble breathing. I went to the ER, where they gave me a mixture of Benadryl, Famotidine, and Prednisone. Was released after a few hours, but the next day, about an hour before my next dose of meds were due, my hives came back on my face, chest, and neck, and my throat became wheezy and tight again. I have never had an allergic reaction to anything in my life, and now I appear to be having one every 24 hours, even with these meds. The only plausible factor that I can attach this to would be the booster. I was also tested for 18 viral strains in the ER, but all of them were negative.
On April 3rd at 6:00 am I awoke with difficulty breathing and intense abdominal pain.  Took my eye medicine (Cyproheptadine 4mg) in the morning, difficulty breathing subsided, but abdominal pain remained.  Became lethargic,  noticed a fever around 9:00 am.  Fever was 100 degrees Fahrenheit.  Chills, muscle pains all over body, nausea, inability to eat, acid reflux, temporary loss of feeling in right toes.  Around noon my fever was 102, and my walking heart rate was 146 bpm (according to fitbit sense watch).  I took two Tylenol tablets (recommended dose 2 for adults according to bottle).  Went to urgent care. Fever subsided, and bpm returned to mostly normal.  Blood draw revealed thrombocytopenia.  Platelets were at 72 (units of measurement), normal range is 150-450 (units of measurement).  I was told recommended hospitalization occurs at 50 (units of measurement).  April 4th. Painful abdomen, lack of appetite, nausea, headache. Took 1 Tylenol. Lethargic. Slept most of the day.  Pain behind my eyes. Headache located in front behind both eyes.  Dry throat. Constantly drinking water and Gatorade, Thirsty.  April 5th.  Headache remains. Pain behind eyes remain. Lack of appetite. Planning for second blood draw on April 7th to check Platelets.
CC:full arrest HPI:HPI and ROS limited due to patient's condition. History is via EMS, medical record, and son.  Per Son patient had Covid vaccine on Saturday morning. Slept all day Sunday. Woke up Sunday night a bit "like coming out of a deep sleep per son, around 10 pm. Shortly after that patient was having a hard time breathing. Emergency called. Arrested around the time EMS arrived. King airway, I/O and CPR initiated. Patient has been in v fib. Was shocked multiple times, given 4 rounds of epi, bicarb and amiodarone. ACLS continued on arrival. Multiple rounds of epi, and attempted defib. Patient given epi, bicarb. Rhythms included fine v fib, asystole, and PEA.  Unrecoverable with no cardiac motion. Time of death 11:50 pm.
Fever of 102-degrees beginning approximately 30 hours post-vaccine, and lasting approximately 15 hours.  In addition, general aches and discomfort throughout body.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unspecified date, the patient received only a partial dose of ZOSTAVAX subcutaneously (lot# and expiration date not reported) because some of the ZOSTAVAX dose leaked out of the space where the needle connects to the syringe. There was no product quality complaint. There were no known adverse effects. Follow up information has been received from a pharmacist. Pharmacist stated, that it was a syringe malfunction and it was not related to ZOSTAVAX. Additional information is not expected, because all follow up information has been obtained.
Nausea and dizziness by evening. Nausea increased. Woke up at 11:45 pm and went to the bathroom. Could not get up from toilet. Too dizzy. Called husband to help. Threw up three times. Body aches and chills came on very quickly. Body aches became severe. Returned to the bathroom about 30 mins later and had bowel movement and some diarrhea. Difficulty sleeping due to the pain from body aches and chills. Fever developed by morning. At 6:00 am fever was 99.8. Took one Advil. Fever subsided. Slept off and on all day. Body aches and chills lasted most of the  next day on 4/13. By 4/14 symptoms lessened. Still feeling queasy in the stomach and weak. Headache in the afternoon around 3:45 pm after waking up from a 30 min nap.
5 days post injection(19th) woke up in the middle of the night with arm pain in the deltoid area which radiated under the arm and into the armpit. Deltoid swollen and firm but not hot. Pain increased the following day(20th) with more deltoid swelling and pain in the arm pit area. Redness noted at injection site size of a quarter the same day with tightness and pain when lifting the arm above the shoulder. Contacted primary care physician and spoke to  RN regarding symptoms on the 21st. Redness increased and extended down the deltoid and bicep area. Itching began that day.  On the 22nd the swelling subsided and by the 23rd the redness disappeared. Still have sensitivity in the deltoid area but swelling gone 4 Feb. Underarm and armpit pain gone by the 24th.
Information has been received from a medical assistant (also reported as office manager) referring to a 18 month old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not provided. On 01-MAY-2017, the patient was vaccinated with the second improperly stored dose of VAQTA (lot # M039202, expiration date: 11-MAR-2018; dose and route of administration were not provided) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccine was involved in Vaccines For Children Program (VFC) stock and the VFC status appointment was reported as 1. The patient received the vaccine with the temperature excursion of 17.6 degrees Celsius for 74 hours and 8 minutes (also reported as 1 hour and 38 minutes). The vaccine was previously exposed to a temperature excursion in 13 degrees Celsius for 72 hours 30 minutes. Data logger was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received. Sender's Comments: US-009507513-1704USA014784:
fever 103-104 q 4hr starting @ 6PM 19FEB98 & 4x3" local rxn on lt arm, red, swelling & indurated;one temp spike to 105 last noc;
on 6th day after vaccine got an intense itching on palms, hands and back. Never had an intense itching like that before almost went to emergency room.  Took benadryl and ibuprofen.  Next morning woke up with rash on back and hands.  Took benadryl second day for intense itching again.  Everything disappear the third morning, no rash or itch.  Only two days of intense itching and rash.   I had a mild covid 19 back in July 2020, bad flu symptoms for 9 days treated at home with doctors knowledge.  Strange but 8 weeks later had the same type rash and itch but not as intense.  Didn't even treat with benadryl but it stayed for three weeks.